Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?

Small cell lung cancer (SCLC) is treated primarily with combination chemotherapy. Despite high initial response rates, most patients eventually die with drug resistant disease. In some tumours, resistance to multiple chemotherapeutic agents is attributed to overexpression of P-glycoprotein (P-gp). H...

Descripción completa

Detalles Bibliográficos
Autores principales: Campling, B. G., Baer, K., Baker, H. M., Lam, Y. M., Cole, S. P.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968549/
https://www.ncbi.nlm.nih.gov/pubmed/8102244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968549/
https://www.ncbi.nlm.nih.gov/pubmed/8102244

Ejemplares similares